Status: Recruiting
Stereotactic Radiotherapy for Cerebral Metastases with Recent Hemorrhagic Signal
This prospective 2-stage, non-randomized Phase 2 trial evaluates the safety and efficacy of FSRT for the management of hemorrhagic brain metastases
Participants needed: 46
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Centre Francois BaclesseUpdated: Feb 11, 2025Locations: 4
Eligibility criteria
Age> 18 years [+21]
Patient with small cell lung cancer, germ cell tumors, lymphoma, leukemia and mu... [+14]